Todd M Bauer
Sarah Cannon Research Institute/ Tennessee Oncology PLLC,
250 25th Ave N, Nashville TN, 37025
Tanzania
Short Communication
Combination Regimens of Mirvetuximab Soravtansine, A Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, With Standard-Of-Care Agents Offer Promise for the Treatment of Ovarian Cancer
Author(s): Todd M BauerTodd M Bauer
DOI:
10.4172/2375-4273.1000195